Vimarsana
Biggest News Aggregation in the World

Page 13 - Trinity Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Trinity Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Trinity Capital Today - Breaking & Trending Today

Trinity Capital Inc. Continues Life Sciences Growth, Hires Industry Veteran Ryan Kaeding as Managing Director - Vimarsana News

Trinity Capital Inc. Continues Life Sciences Growth, Hires Industry Veteran Ryan Kaeding as Managing Director

PHOENIX, Dec. 18, 2023 /PRNewswire/ -- Trinity Capital Inc. , a leading provider of diversified financial solutions to growth-stage companies, today announced the appointment of Ryan Kaeding as...

Trinity Capital Inc. Provides $45 Million Growth Capital to Neurolens - Vimarsana News

Trinity Capital Inc. Provides $45 Million Growth Capital to Neurolens

/PRNewswire/ -- Trinity Capital Inc. (NASDAQ: TRIN) ("Trinity"), a leading provider of diversified financial solutions to growth-stage companies, today...

Trinity Capital Inc. (NASDAQ:TRIN) Shares Sold by Clearbridge Investments LLC - Vimarsana News

Trinity Capital Inc. (NASDAQ:TRIN) Shares Sold by Clearbridge Investments LLC

Clearbridge Investments LLC lowered its stake in shares of Trinity Capital Inc. (NASDAQ:TRIN – Free Report) by 57.3% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 196,349 shares of the company’s stock after selling 263,963 shares during the period. Clearbridge Investments LLC owned 0.53% of […]

CORE SCIENTIFIC : AND ITS AFFILIATED DEBTORS - Form 8-K -November 17, 2023 at 07:55 am EST - Vimarsana News

CORE SCIENTIFIC : AND ITS AFFILIATED DEBTORS - Form 8-K -November 17, 2023 at 07:55 am EST

CORE SCIENTIFIC, INC. AND ITS AFFILIATED DEBTORS WEIL, GOTSHAL & MANGES LLP ...

Taysha Gene Therapies Inc (TSHA) Reports Q3 2023 Financial Results and Clinical Progress - Vimarsana News

Taysha Gene Therapies Inc (TSHA) Reports Q3 2023 Financial Results and Clinical Progress

Key Clinical Advances and Financial Position Strengthened; Cash Runway Extended into 2026

Source: yahoo.com